PharmaShots Weekly Snapshots (August 23, 27, 2021)
Published: Aug 27, 2021 | Tags: Ascendis, Skytrofa, lonapegsomatropin-tcgd, US, FDA, Approval, Pediatric Growth Hormone Deficiency
Published: Aug 27, 2021 | Tags: Amgen, Repatha, evolocumab, P-III, HUYGENS Study, Acute Coronary Syndrome, ESC 2021
Innovent Collaborates with Bolt to Develop Three Oncology Boltbody ISAC Programs
Published: Aug 27, 2021 | Tags: Innovent, Bolt, Develop, Boltbody ISAC Programs
Published: Aug 27, 2021 | Tags: BeyondSpring, Commercialization Agreement, Jiangsu Hengrui, Co- Develop, Commercialize, Plinabulin, Greater China
Published: Aug 27, 2021 | Tags: MorphoSys, Incyte, Minjuvi, tafasitamab, Lenalidomide, EC, Approval, R/R DLBCL
NovaRock Signs an Exclusive License Agreement with Flame to Co-Develop and Commercialize NBL-015
Published: Aug 27, 2021 | Tags: NovaRock, Flame, Co-Develop, Commercialize, NBL-015
Published: Aug 26, 2021 | Tags: AstraZeneca, ALXN1840, P-III, FoCus Trial, Wilson Disease
Published: Aug 26, 2021 | Tags: Pfizer, BioNTech, Rolling Submission, sBLA, US, FDA, Approval, Comirnaty Booster Dose
Published: Aug 26, 2021 | Tags: AstraZeneca, Forxiga, dapagliflozin, MHLW, Approval, Chronic Kidney Disease
Published: Aug 26, 2021 | Tags: Merck, Vaxneuvance, pneumococcal 15-valent conjugate vaccine, P-III, PNEU-PED Study, Invasive Pneumococcal Disease
Published: Aug 26, 2021 | Tags: Thermo Fisher, Oncomine Dx Target Test, US, FDA, Approval, CDx, IDH1-Mutated Cholangiocarcinoma
Lilly Signs a License Agreement with Lycia to Develop Novel LYTAC Degraders
Published: Aug 26, 2021 | Tags: Lilly, Lycia, LYTAC Degraders
Published: Aug 25, 2021 | Tags: Cara, Vifor, Korsuva, difelikefalin, US, FDA, Approval, Pruritus, Hemodialysis
Argenx Reports EMAs Validation of MAA for Efgartigimod to Treat Generalized Myasthenia Gravis
Published: Aug 25, 2021 | Tags: Argenx, EMA, MAA, Efgartigimod, Generalized Myasthenia Gravis
Published: Aug 25, 2021 | Tags: Ono, Takeda, Opdivo, nivolumab, Cabometyx, cabozantinib, MHLW, Approval, Renal Cell Carcinoma, Japan
Vertex Expands its 2018 Agreement with Arbor to Develop Novel Ex Vivo Engineered Cell Therapies
Published: Aug 25, 2021 | Tags: Vertex, Arbor, Ex Vivo Engineered Cell Therapies, CRISPR Gene-Editing Technology
Published: Aug 25, 2021 | Tags: AbbVie, Rinvoq, upadacitinib, EC, Approval, for the Treatment of Moderate to Severe Atopic Dermatitis
Published: Aug 25, 2021 | Tags: Roche, Shape, AAV-based RNA Editing Technology, Neuroscience, Rare Disease
Published: Aug 24, 2021 | Tags: UCB, Bimzelx, bimekizumab, EC, Approval, Plaque Psoriasis
Published: Aug 24, 2021 | Tags: Novartis, Kymriah, tisagenlecleucel, P-III, BELINDA Study, Aggressive B-Cell Non-Hodgkin Lymphoma
Published: Aug 24, 2021 | Tags: Merck KGaA, GSK, Discontinue, P-II, INTR@PID BTC 055 Study, Bintrafusp Alfa, Biliary Tract Cancer
Published: Aug 24, 2021 | Tags: Theravance, Izencitinib, P-IIb, Dose-Finding, Induction Study, Ulcerative Colitis
Published: Aug 24, 2021 | Tags: Takeda, Genevant, Novel Nonviral Gene Therapies, Liver Diseases
Published: Aug 24, 2021 | Tags: Pfizer-BioNTech, Covid-19 Vaccine, Comirnaty, US, FDA, Approval, COVID-19
Pfizer to Acquire Trillium for ~$2.26B
Published: Aug 23, 2021 | Tags: Pfizer, Acquire, Trillium, ~$2.26B
Published: Aug 23, 2021 | Tags: Alexion, P-III, CHAMPION-ALS Trial, Ultomiris, ravulizumab, Amyotrophic Lateral Sclerosis
Zydus' ZyCoV-D Receives the DCGIs EUA for the Treatment of COVID-19
Published: Aug 23, 2021 | Tags: Zydus, ZyCoV-D, DCGI, EUA, COVID-19
Published: Aug 23, 2021 | Tags: Pfizer, Xeljanz, tofacitinib citrate, EC Approval, Active Polyarticular JIA, Juvenile PsA
Published: Aug 23, 2021 | Tags: BeiGene, NMPA, sBLA, Tislelizumab, Nasopharyngeal Cancer, China
Published: Aug 23, 2021 | Tags: BMS, Opdivo, nivolumab, US, FDA, Approval, Urothelial Carcinoma
Related Post: PharmaShots Weekly Snapshots (August 16, 20, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com